AbbVie Inc. (ABBV) EPS Estimated At $1.92; Peconic Partners Has Raised Crown Castle Intl New (CCI) Holding By $2.22 Million

Crown Castle International Corp. (NYSE:REIT) Logo

Analysts expect AbbVie Inc. (NYSE:ABBV) to report $1.92 EPS on January, 25 before the open.They anticipate $0.44 EPS change or 29.73% from last quarter’s $1.48 EPS. ABBV’s profit would be $2.89B giving it 11.48 P/E if the $1.92 EPS is correct. After having $2.14 EPS previously, AbbVie Inc.’s analysts see -10.28% EPS growth. The stock increased 0.44% or $0.39 during the last trading session, reaching $88.2. About 6.53M shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since January 11, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 16/04/2018 – Dynavax Reports Interim Data for SD-101 in Combination With KEYTRUDA(R) (pembrolizumab) in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck; 10/04/2018 – AbbVie: Elagolix Clinical Trial Program Largest Prospective Randomized Endometriosis Trial Conducted to Date; 06/04/2018 – INCYTE- SAFETY PROFILE OBSERVED IN ECHO-301/KEYNOTE-252 WAS CONSISTENT WITH THAT OBSERVED IN STUDIES OF EPACADOSTAT IN COMBINATION WITH KEYTRUDA; 12/03/2018 – AstraZeneca Says Phase 3 Trial Results for Imfinzi Antibody Delayed; 22/03/2018 – ABBVIE INC – SAFETY DATA IN TRINITY STUDY WERE CONSISTENT WITH PREVIOUSLY REPORTED STUDIES OF ROVA-T; 25/05/2018 – AstraZeneca: Imfinzi Met Second Primary Endpoint of Overall Survival; 09/04/2018 – ABBVIE: UPADACITINIB MEETS ALL PRIMARY, SECONDARY ENDPOINTS; 22/03/2018 – BerGenBio ASA: BerGenBio to present overview of phase II clinical trial portfolio combining bemcentinib with KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe; 14/03/2018 – Pfizer wins bid to supply Enbrel to Pusan National University Hospital, insiders say; 21/03/2018 – AbbVie and the International Myeloma Foundation Announce Partnership to Study the Role of a Genetic Mutation in Outcomes of Pat

Peconic Partners Llc increased Crown Castle Intl Corp New (CCI) stake by 72.73% reported in 2018Q3 SEC filing. Peconic Partners Llc acquired 20,000 shares as Crown Castle Intl Corp New (CCI)’s stock rose 3.08%. The Peconic Partners Llc holds 47,500 shares with $5.29 million value, up from 27,500 last quarter. Crown Castle Intl Corp New now has $44.33B valuation. The stock increased 1.12% or $1.18 during the last trading session, reaching $106.85. About 2.28M shares traded. Crown Castle International Corp. (NYSE:CCI) has risen 5.82% since January 11, 2018 and is uptrending. It has outperformed by 5.82% the S&P500.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company has market cap of $132.67 billion. The firm offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It has a 18.42 P/E ratio. It also provides Kaletra, an anti- human immunodeficiency virus-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants.

Investors sentiment decreased to 0.82 in 2018 Q3. Its down 0.12, from 0.94 in 2018Q2. It fall, as 60 investors sold AbbVie Inc. shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Gam Ag owns 77,974 shares for 0.27% of their portfolio. Moreover, Pekin Singer Strauss Asset Management Il has 0.63% invested in AbbVie Inc. (NYSE:ABBV). Rothschild Inv Corporation Il reported 2% of its portfolio in AbbVie Inc. (NYSE:ABBV). Essex Investment Mngmt Llc has invested 0.07% in AbbVie Inc. (NYSE:ABBV). Dynamic Advisor Solutions Limited Liability Company owns 37,176 shares. New Mexico Educational Retirement Board has 135,142 shares. Retail Bank Of Hawaii owns 107,748 shares. Vigilant Management Ltd Liability Corporation accumulated 208,874 shares. Parkside Retail Bank Trust holds 10,827 shares or 0.35% of its portfolio. First Heartland Consultants Inc accumulated 4,278 shares or 0.13% of the stock. Cortland Mo holds 0.03% or 2,334 shares in its portfolio. Csat Investment Advisory Lp invested in 13 shares or 0% of the stock. Ghp Inc, a Colorado-based fund reported 5,718 shares. First Bancshares Of Omaha accumulated 0.1% or 18,715 shares. North Management Corporation holds 0.17% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 11,309 shares.

Among 5 analysts covering AbbVie (NYSE:ABBV), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. AbbVie had 8 analyst reports since July 12, 2018 according to SRatingsIntel. The rating was maintained by Bank of America with “Buy” on Monday, July 30. Bank of America maintained the shares of ABBV in report on Wednesday, August 22 with “Buy” rating. BMO Capital Markets maintained the stock with “Underperform” rating in Monday, November 5 report. The company was downgraded on Thursday, January 3 by Bank of America. Bank of America maintained it with “Buy” rating and $106 target in Thursday, October 4 report. Argus Research maintained the shares of ABBV in report on Tuesday, November 6 with “Buy” rating.

Since August 17, 2018, it had 0 insider buys, and 6 insider sales for $26.66 million activity. SEVERINO MICHAEL had sold 50,000 shares worth $4.88M. 16,850 AbbVie Inc. (NYSE:ABBV) shares with value of $1.50 million were sold by GONZALEZ RICHARD A. Another trade for 25,000 shares valued at $2.25 million was made by Schumacher Laura J on Friday, December 28. 60,000 shares were sold by CHASE WILLIAM J, worth $5.40M. Gosebruch Henry O sold $3.82 million worth of AbbVie Inc. (NYSE:ABBV) on Thursday, November 29.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie – Stemcentrx Impairment, A Worrying Sign? – Seeking Alpha” on January 10, 2019, also Seekingalpha.com with their article: “AbbVie revamps senior management – Seeking Alpha” published on December 17, 2018, Fool.com published: “3 Dividend Stocks That Pay You Better Than Coca-Cola Does – The Motley Fool” on January 10, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition – Seeking Alpha” published on January 10, 2019 as well as Seekingalpha.com‘s news article titled: “AbbVie boosts stock buybacks by $5B – Seeking Alpha” with publication date: December 13, 2018.

Since August 29, 2018, it had 2 insider purchases, and 1 insider sale for $396,868 activity. 5,478 shares valued at $580,610 were bought by Melone Anthony J. on Tuesday, October 23. $279,310 worth of Crown Castle International Corp. (NYSE:REIT) was sold by GARRISON ROBERT E II. 900 shares were bought by CHRISTY LANGENFELD CYNTHIA K, worth $95,568 on Monday, October 22.

Among 4 analysts covering Crown Castle Intl (NYSE:CCI), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Crown Castle Intl had 4 analyst reports since July 24, 2018 according to SRatingsIntel. Wells Fargo maintained the stock with “Outperform” rating in Wednesday, December 12 report. Morgan Stanley maintained it with “Overweight” rating and $118 target in Thursday, August 16 report. Barclays Capital maintained it with “Equal-Weight” rating and $112 target in Friday, October 19 report. The rating was maintained by Citigroup on Tuesday, July 24 with “Neutral”.

Investors sentiment increased to 1.08 in 2018 Q3. Its up 0.02, from 1.06 in 2018Q2. It improved, as 29 investors sold CCI shares while 234 reduced holdings. 86 funds opened positions while 198 raised stakes. 377.74 million shares or 1.71% less from 384.32 million shares in 2018Q2 were reported. Tocqueville Asset Limited Partnership reported 3,655 shares. Smith Asset Mngmt Group Ltd Partnership invested 0.13% of its portfolio in Crown Castle International Corp. (NYSE:REIT). State Bank Of Hawaii has 0.14% invested in Crown Castle International Corp. (NYSE:REIT). Dubuque Bancshares Tru owns 49 shares for 0% of their portfolio. Mason Street Advsrs Ltd Com owns 58,318 shares. Rfg Advisory Group has 0.17% invested in Crown Castle International Corp. (NYSE:REIT) for 5,692 shares. Moreover, Federated Investors Pa has 1.94% invested in Crown Castle International Corp. (NYSE:REIT) for 7.48 million shares. Td Asset Management Incorporated has invested 0.1% in Crown Castle International Corp. (NYSE:REIT). Balyasny Asset Mngmt stated it has 29,321 shares. Thornburg Investment Mgmt reported 2.15 million shares or 2% of all its holdings. Colony Lc holds 0.61% in Crown Castle International Corp. (NYSE:REIT) or 109,596 shares. Jennison Limited Liability Corporation holds 0.22% or 2.17 million shares in its portfolio. 305,000 were reported by Eventide Asset Lc. Brown Advisory Incorporated holds 0.18% in Crown Castle International Corp. (NYSE:REIT) or 557,818 shares. Spinnaker accumulated 38,971 shares or 0.43% of the stock.

Peconic Partners Llc decreased Quanta Svcs Inc (NYSE:PWR) stake by 1.71M shares to 3.07 million valued at $102.54 million in 2018Q3. It also reduced Hi (NYSE:HCLP) stake by 67,380 shares and now owns 45,000 shares. Mastec Inc (NYSE:MTZ) was reduced too.

AbbVie Inc. (NYSE:ABBV) Ratings Chart